Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000899225 | SCV001043479 | benign | not provided | 2019-12-31 | criteria provided, single submitter | clinical testing | |
Juno Genomics, |
RCV004796275 | SCV005416743 | uncertain significance | Ovarian dysgenesis 5 | criteria provided, single submitter | clinical testing | PVS1_Strong+BS1 | |
OMIM | RCV000679811 | SCV000807191 | pathogenic | Spermatogenic failure 32 | 2018-09-11 | no assertion criteria provided | literature only | |
Reproductive Health Research and Development, |
RCV000991169 | SCV001142406 | pathogenic | Spermatogenic Failure | 2020-01-06 | no assertion criteria provided | curation | NG_033784.1(NM_001101677.1):c.346-1G>A in the SOHLH1 gene has an allele frequency of 0.015 in European (Finnish) subpopulation in the gnomAD database. 5 homozygous occurrences are observed in the gnomAD database. This variant destroys the canonical splice donor site. It is was predicted to lead to skipping of exon 4 or activation of a cryptic splice acceptor site in exon 4. The c.346-1G>A has been detected in two individuals with non-obstructive azoospermia (PMID: 20506135, 28718531). In the patient reported by Nakamura (PMID: 20506135), c.346-1G>A mutation was not detected in both parents of each probands, indicating a de novo event. We interpret it as Pathogenic/Likely pathogenic. ACMG/AMP criteria applied: PVS1, PS2, PP4, BS1. |